11-15-2023 Elevate Your BioScience Expertise With The Leading Experts in Venture Capital and Private Equity Investments

Wednesday, 4:00 pm - 5:30 pm

Zoom Meeting


Michele Colucci, ESQ — Founder & Managing Partner, DigitalDX Ventures
Michelle Detwiler, MD, PhD — Co-founder, Biospring Partners
Paul Yook — Partner & CIO, LifeSci Venture Partners

Mark Cabato, CFA — Chief Business Officer, Immunis

Agenda: 4pm-5pm: Panel Discussion
5pm-5:30pm: Q&A Session
Add to Calendar 11/15/2023 4:00 PM 11/15/2023 5:30 PM America/Los_Angeles Elevate Your Bioscience Expertise with the Leading Experts in Venture Capital and Equity Investments Zoom Meeting CFALA info@cfala.org false MM/DD/YYYY
An Alternative Investment Advisory Council Sponsored Event 

Since the discovery of MRNA vaccines to tackle the COVID 19 pandemic the biotech sector has seen a boom in investments. In total, the biotech companies raised more than $60bn globally easily outpacing the fund-raising totals of the last decade. Fueled by advances in the development of drugs tackling chronic diseases like diabetes and obesity, the industry is rapidly investing into cell therapy, precision medicine, biologics, gene therapy and life science services/equipment.

With many fascinating areas emerging in biotech investing, venture and private equity funds offer the possibility for outsized and uncorrelated returns. We have gathered three leading founders to discuss the environment and opportunities, including how AI could impact the industry. Get up to speed on this complicated area and learn from some of the best.


Michele Colucci, ESQ | Michele Colucci, Founder & Managing Partner, is a lawyer, investor, serial entrepreneur, and philanthropist. She has authored six patents in the technology space and founded companies in the legal, technology, retail, and entertainment spaces. Michele’s extensive experience operating in highly regulated verticals has focused on issues from management to legal (employment, corporate, International, litigation, torts, negotiations, business strategy, and marketing). Her most recent company focused on the application of big data and artificial intelligence in legal technology. She has worked at law firms including Hughes Hubbard & Reed, run her own media production company, owned and operated a chain of retail stores in the political space, run a political fundraising venue, and founded a legal technology company.

Currently, Michele serves on the Boards of Directors Nephrosant, Optina Diagnostics, Prime Genomics, and Delphi Diagnostics and previously the Global Indemnity Group. She is also an Advisor to eHealth Analytics (a digital health startup) and Quantellia (a platform powering decision-based analytics through artificial intelligence). She has blogged for the Huffington on female entrepreneurship and is an award-winning expert on E-Local. She served as a guest lecturer and mentor at Stanford University’s School of Engineering focused on Global Marketing and Entrepreneurship and has lectured at USF in marketing and at USC’s Gould School of Law. Back To Top ^^

Michelle Detwiler, MD, PhD| Michelle has over a decade of healthcare private equity and venture capital expertise. She currently serves on the Board of Directors of two Biospring portfolio companies, Abzena and Kiniciti. Michelle was previously a Managing Director at General Atlantic where she launched the firm’s first life sciences investment platform and led multiple investments including Ginkgo BioWorks (NYSE: DNA), Motif FoodWorks, PathAI, Immunocore (NASDAQ: IMCR) and Ocumension (HK: 1477). Prior to General Atlantic, Michelle was Co-Founder and General Partner of Longwood Fund, a leading healthcare investment firm based in Boston. Prior to Longwood, Michelle was the Senior Vice President of the CEEDD at GlaxoSmithKline (NASDAQ: GSK), leading global business development and M&A.

Michelle holds a Bachelor of Medicine and Bachelor of Surgery from the University of Oxford Medical School and a Doctor of Philosophy in Human Physiology from the University of Oxford. Born and raised in El Paso, Texas, Michelle is passionate about education and healthcare in underserved populations. Back To Top ^^

Paul Yook | Paul has over 20 years of healthcare investment and finance experience and in 2017 founded LifeSci Venture Partners and serves as CIO and Portfolio Manager. In 2014, Paul launched the BioShares biotechnology ETFs (NYSE: BBC & BBP) which utilize innovative and sector-specific passive index strategies and have delivered the strongest performance metrics (Sharpe ratio and total return) in their class. He previously worked at Galleon Management, as a research analyst and healthcare hedge fund portfolio manager, and in the healthcare investment banking groups of Goldman Sachs and UBS.

Paul is a passionate surfer, having lived for 3 years in Hawaii, is a mediocre but improving chess player in an effort to keep up with his two young kids, and makes an outstanding açaí bowl. He earned a B.S.E in Economics from the Wharton School and a B.A. in Biochemistry from the College of Arts and Sciences at the University of Pennsylvania.Back To Top ^^


Mark Cabato, CFA | Mark has more than 20 years of healthcare finance experience having spent the last 15 years at a large global financial institution where he was recently a director in the healthcare corporate and investment banking unit. He was responsible for large global pharmaceutical sector coverage and provided both financial solutions collaborating with multiple product groups across the globe as well as strategic advice primarily to U.S. and Japanese pharmaceutical companies and biotechs working closely with the global M&A team.

Mark brings strong relationships with a broad range of pharma and biotech executives, corporate development, and other industry leaders and is well respected for his thoughtful perspective and analytical skills. Mark also combines a deep strategic understanding of the biopharma industry and capital markets with breadth of experience in strategic planning, business development, and life science valuation. His versatility and collaborative mind-set will be important in forging new strategic growth opportunities and are a welcomed and valuable addition to the Immunis team.

Mark has a BS in Civil Engineering from Bucknell University, an MA in Communication Management from the University of Southern California and is a CFA Charterholder and member of the CFA Society of Los Angeles. Back To Top ^^

Registration Fees
Free (Members) | $20 (Non-Members)

Payment Information
We accept the following:

If you prefer to pay by check please email info@cfala.org and request to pay by check. Your registration will be completed manually and you will receive an email confirmation.

Mail Check To:
CFA Society of Los Angeles
13400 Riverside Drive, Ste. 215
Sherman Oaks, CA 91423

*Credit card payments will only be accepted through the secure online registration, and not by phone or email.

Cancellations must be received in writing by 9:00 am the day prior to the event to receive a refund. No phone cancellations are accepted. Please e-mail info@cfala.org.
Y. Allen Kim, CFA
As a participant in the CFA Institute Approved-Provider Program, the CFA Society of Los Angeles has determined that this program qualifies for 1.5 credit hour. If you are a CFA Institute member, CE credit for your participation in this program will be automatically recorded in your CE Diary.
YouTube Facebook Twitter Instagram LinkedIn